MicroRNAs (miRNAs) play a pivotal role in regulating
gene expression
and are considered new molecular targets in bone tissue engineering.
However, effective delivery of miRNAs to the defect areas and transfection
of the miRNAs into osteogenic progenitor cells has been an obstacle
in the application. In this work, miRNA-218 (miR-218) was used as
an osteogenic miRNA regulator, and a multifunctional peptide-conjugated
gene carrier poly(lactide-co-glycolide)-g-polyethylenimine-b-polyethylene glycol-R9-G4-IKVAVW (PPP-RGI) was developed to condense with miR-218
to form PPP-RGI/miR-218 complexes that were further encapsulated into
monodisperse injectable microspheres for enhanced bone regeneration.
The PPP-RGI was synthesized via conjugating R9-G4-IKVAVW (RGI), a multifunctional peptide, onto
poly(lactide-co-glycolide)-g-polyethylenimine-b-polyethylene glycol (PPP). A microfluidic and synchronous
photo-cross-linking process was further developed to encapsulate the
PPP-RGI/miR-218 complexes into monodisperse gelatin methacryloyl microspheres.
The monodisperse microspheres controlled the delivery of PPP-RGI/miR-218
to the designated defect site, and PPP-RGI facilitated the transfection
of miR-218 into osteogenic progenitor cells. An in vivo calvarial defect model showed that the PPP-RGI/miR-218-loaded microspheres
significantly enhanced bone tissue regeneration. This work provides
a novel approach to effectively deliver miRNA and transfect targeting
cells in vivo for advanced regenerative therapies.